Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Clinical trial NCT06791291 · RECRUITING

Trial details

NCT number: NCT06791291
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2025-07-25
Primary completion: 2028-03-06
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.